MINERAL WELLS, Texas--(BUSINESS WIRE)-- Pulvinar Neuro, a wholly owned subsidiary of Electromedical Products International, Inc. (EPI) developing non-invasive brain stimulation devices, was awarded a grant from the National Institutes of Health (NIH) to further its research in transcranial stimulation (TCS) as a potential treatment for psychiatric disorders.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230516005498/en/

The three-year, $3.06 million Phase II SBIR grant from the NIH’s National Institute of Mental Health (NIMH) will be used to develop a cloud-enabled TCS device that delivers personalized closed-loop brain stimulation for clinical and at-home applications. The grant also includes funding for a double-blind, placebo-controlled study of the cloud-enabled TCS device in 30 patients with major depressive disorder.

“This NIH grant will enable us to take a key step forward in the development of our novel brain stimulation treatment for mental illness,” said Leah Townsend, Ph.D., chief science officer, EPI. “We are grateful to NIMH for supporting our work developing this important, innovative technology.”

Pulvinar is a wholly owned subsidiary of Electromedical Products International, Inc. (EPI). Research reported in this press release was supported by the National Institute of Mental Health of the National Institutes of Health under award number R44MH119872. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About Electromedical Products International, Inc. (EPI)

EPI is a leading medical device company in non-invasive brain stimulation for psychiatric disorders and pain management. EPI manufactures the Alpha-Stim® brand of patented devices that are FDA cleared to provide fast, safe, and effective treatment of anxiety and insomnia via cranial electrotherapy stimulation (CES) and pain via microcurrent electrical therapy (MET). Alpha-Stim is available in more than 50 countries worldwide and is available via prescription in the U.S. Learn more at www.alpha-stim.com.

About Pulvinar Neuro, LLC

Pulvinar Neuro is a neurotechnology company dedicated to supporting the research community with cutting-edge non-invasive brain stimulation research tools as well as the technical development of innovative therapeutics to address some of the most pressing challenges in mental health. Learn more at www.pulvinarneuro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230516005498/en/